Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Equity Ratio (2021 - 2025)

Historic Equity Ratio for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 0.85.

  • Molecular Partners Ag's Equity Ratio fell 534.78% to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year decrease of 534.78%. This contributed to the annual value of 0.89 for FY2024, which is 44.64% up from last year.
  • Latest data reveals that Molecular Partners Ag reported Equity Ratio of 0.85 as of Q3 2025, which was down 534.78% from 0.86 recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Equity Ratio peaked at 911802.46 during Q2 2024, and registered a low of 0.62 during Q4 2021.
  • For the 5-year period, Molecular Partners Ag's Equity Ratio averaged around 168361.7, with its median value being 0.9 (2022).
  • Per our database at Business Quant, Molecular Partners Ag's Equity Ratio surged by 4431.2% in 2022 and then crashed by 9999.99% in 2025.
  • Quarter analysis of 5 years shows Molecular Partners Ag's Equity Ratio stood at 0.62 in 2021, then surged by 44.31% to 0.9 in 2022, then dropped by 0.81% to 0.89 in 2023, then rose by 0.45% to 0.89 in 2024, then fell by 4.66% to 0.85 in 2025.
  • Its Equity Ratio was 0.85 in Q3 2025, compared to 0.86 in Q2 2025 and 0.91 in Q1 2025.